A label-free microLC-SWATH-MS methodology with immunoaffinity depletion of highly abundant serum proteins for quantitative proteomic comparison of fresh-frozen human normal breast tissue and tumor clinical specimens
{{output}}
Background: Mass spectrometry (MS)-based proteomics can provide deep insights into protein-driven molecular processes and signaling pathways in breast cancer, thereby contributing to improvements in disease diagnosis, treatment, ... ...
